Everlinq Reports Successful New Approach to Vascular Access

The everlinQ^TM System forms an HD access with radiofrequency energy at sites not traditionally used by surgeons. The system has CE Mark approval, but is not yet available in the U.S.

Read the full article » | Posted 12-10-2015

Related Articles

• Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
• AWAK PD To Go Posted 10-05-2026
• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026